WHO Grants Emergency Approval to India’s Covovax to Boost Vaccination in Lower-Income Countries

WHO Grants Emergency Approval to India’s Covovax to Boost Vaccination in Lower-Income Countries
A medical worker prepares to administer a dose of the COVID-19 vaccine at a vaccination center in New Delhi, India, on Feb. 22, 2021. Sajjad Hussain/AFP via Getty Images
|Updated:

The World Health Organization (WHO) on Friday has granted emergency approval for the India-made coronavirus vaccine NVX-CoV2373, also known as Covovax, to vaccinate more people in lower-income countries.

“This listing aims to increase access particularly in lower-income countries, 41 of which have still not been able to vaccinate 10 percent of their populations, while 98 countries have not reached 40 percent,” Dr. Mariangela Simao, assistant-director general at WHO, said in a statement.
Related Topics